Expired Manager Statistical Programming jobs in Santa Fe, NM
avatar-of-creator
Loxo@Lilly
Manager, Programming, Scientific Systems
Santa Fe, NM
$46,245-$168,660/year (est.)
About Loxo@Lilly: Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for...
Read More
avatar-of-creator
Sumitomo Pharma
Senior Manager, Statistical Programming
Santa Fe, NM
$124K-$163K / yr.
Senior Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s...
Read More
LabCorp jobs
LabCorp
Manager Stats Programming
Santa Fe, NM
$46,245-$168,660/year (est.)
Manager, Statistical Programming required to work for Labcorp Drug Development. You will be employed by Labcorp Drug Development working in our late phase (II-IV) full-service group with the opportunity to work across multiple therapeutic areas Home based anywhere in the US or Canada. You must have...
Read More
State of New Mexico jobs
State of New Mexico
Manager PSD Data Evaluation (CYFD/P & A #74359)
Santa Fe, NM
$60K-$96K / yr.
$28.72 - $45.95 Hourly $59,739 - $95,582 Annually This position is a Pay Band 75 Posting Details THIS POSTING WILL BE USED FOR ONGOING RECRUITMENT AND MAY CLOSE AT ANY TIME. APPLICANT LISTS MAY BE SCREENED MORE THAN ONCE. Why does the job exist? This job exists to manage, coordinate and supervise...
Read More
avatar-of-creator
Sumitomo Pharma
Manager, Statistical Programming
Santa Fe, NM
$99K-$131K / yr.
Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse...
Read More